-
-
-
-
-
-
-
AquaBounty Technologies, Inc. Announces Pricing of $5.75 Million Public Offering of Common Stock
-
-
-
-
-
-
-
CORRECTION – AquaBounty Technologies, Inc.
-
-
-
-
-
-
-
Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for First-in-Class PRGN-3006 UltraCAR-T™ Therapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) and Higher Risk
-
-
-
-
-
-
-
Fibrocell Announces Closing of $6.0 Million Registered Direct Offering
-
-
-
-
-
-
-
Intrexon (XON) Prices 6M Common Stock Offering at $12.50/Share
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 08/15: (FFHL) (BIOL) (XON) Higher; (SUMR) (MTSL) (LWAY) Lower
68,144 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

